FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/071853 [Registered on: 02/08/2024] Trial Registered Prospectively
Last Modified On: 02/08/2024
Post Graduate Thesis  Yes 
Type of Trial  PMS 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Clinical trial to Compare the efficacy of two different doses of sugammadex for reversal of vecuronium induced neuromuscular blockage in patients posted for elective surgeries under general anesthesia 
Scientific Title of Study   Comparision of the efficacy of two different doses of sugammadex for reversal of vecuronium induced neuromuscular blockage in patients posted for elective surgeries under general anesthesia 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Divyeshkumar Gajjar 
Designation  Resident doctor 
Affiliation  GMC Bhavnagar gujarat 
Address  Department of Anesthesiology,1st floor,Near main operation theater,Sir T hospital bhavnagar 364001

Bhavnagar
GUJARAT
364001
India 
Phone  9624037769  
Fax    
Email  dr.divyeshgajjar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Komal Shah 
Designation  Associate Professor 
Affiliation  GMC Bhavnagar gujarat 
Address  Department of Anesthesiology,1st floor near main operation theater,Sir T hospital, Bhavnagar, Gujarat – 364001

Bhavnagar
GUJARAT
364001
India 
Phone  9427215252  
Fax    
Email  shah.komal212@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Komal Shah 
Designation  Associate Professor 
Affiliation  GMC Bhavnagar gujarat 
Address  Department of Anesthesiology,1st floor near main operation theater,Sir T hospital, Bhavnagar, Gujarat – 364001

Bhavnagar
GUJARAT
364001
India 
Phone  9427215252  
Fax    
Email  shah.komal212@gmail.com  
 
Source of Monetary or Material Support  
Department of anaesthesiology,Government medical college,Kalanala road,Bhavnagar,Gujarat,India 364001 
 
Primary Sponsor  
Name  GOVERNMENT MEDICAL COLLEGE BHAVNAGAR  
Address  Department of Anesthesiology,1st floor near main operation theater,Sir T hospital, Bhavnagar, Gujarat – 364001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrDivyeshkumar Gajjar  Sir Takhtasinhji Hospital, Bhavnagar  Main operation theater,Above blood bank,Sir T. General Hospital, jail road, Kalanala Bhavnagar
Bhavnagar
GUJARAT 
9624037769

dr.divyeshgajjar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethics committee govt medical college bhavnagar  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: 8||Other Procedures,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Inj.Sugammadex 1mg/kg  Compare efficacy of reversal by Inj.Sugammadex dose 1mg/kg with 2mg/kg in vecuronium induced neuromuscular blockage after T2 appearance on TOF 
Comparator Agent  Inj.Sugammadex 2mg/kg  Compare efficacy of reversal by Inj.Sugammadex dose 2mg/kg with 1mg/kg in vecuronium induced neuromuscular blockage after T2 appearance on TOF 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1 Age 18 to 60 years
2 ASA grade 1 to 3
3 schedule for elective surgery under general anesthesia
4 Surgery duration less than 2 hours
5 BMI less than30 
 
ExclusionCriteria 
Details  Suspected difficult intubation
Significant hepatic and renal dysfunction
Any suspected neuromuscular disorder
Known or suspected family history of malignant hyperthermia
Lactating or pregnant female
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare clinical recovery profile of two different dose of sugammadex in terms of time require for spontaneous eye opening, adequate tidal volume (5ml/kg) , hand grip for 5 seconds and time requires for extubation.
 
At baseline,Immediate after Inj.sugammadex and after 5min,10min,15min,30min,60min,90 min,120min after Inj.sugammadex  
 
Secondary Outcome  
Outcome  TimePoints 
1. To compare the hemodynamic changes(Mean arterial pressure, Heart rate) after Inj. sugammadex
2. Side effects (If any) after Inj. sugammadex in both groups.
 
At baseline,Immediate after Inj.sugammadex & after 5min,10min,15min,30min,60min,90 min,120min after Inj.sugammadex  
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   03/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Sugammadex is novel drug launched in india for reversal of vecuronium induced neuromuscular blockage in patients undergoing general anesthesia,but there are very few studies available for it’s optimal dosing .In this study we compare the effectiveness of two minimal dosing of inj sugammadex.
In this study there will be two groups ,one will receive inj,sugammadex 1mg/kg dose and other will receive 2mg/kg dose, We will compare the clinical recovery profile of this two minimal doses .

Study design                           :A prospective, double blind study.

Study setting                           :Operation theatre, Sir Takhtasinhji Hospital, Bhavnagar.

Study duration                        :15 months

Duration of data collection    :12 months

Sample size                              : Patients undergoing elective surgical procedure requiring general anesthesia on Tuesday and Friday during study duration period

Sampling method                   :Convenient sampling

Randomization                      :Patient will be allocated into one of the study group by computer generated  random numbers     

                                                


 
Close